Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AACR 2022 | Potential trends in the molecular profiling of breast cancer

Sofia Mastoraki • 11 Apr 2022
AACR 2022
Breast Cancer

Sofia Mastoraki, PhD, University of Texas MD Anderson Cancer Center, Houston, TX discusses molecular profiling and the need for biomarkers which can predict responses to immunotherapy in patients with breast cancer. This interview took place at the American Association for Cancer Research (AACR) Annual Meeting 2022 in New Orleans, LA.

More from Sofia Mastoraki

Advantages and disadvantages of next-generation sequencing techniques for tumor research
1:14
Advantages and disadvantages of next-generation sequencing techniques for tumor research
Sofia Mastoraki • 11 Apr 2022
Using single cell technologies to identify biomarkers for breast cancer patient outcomes
1:39
Using single cell technologies to identify biomarkers for breast cancer patient outcomes
Sofia Mastoraki • 11 Apr 2022

Related Videos

How will SARMs fit into the current breast cancer treatment paradigm?
1:14
How will SARMs fit into the current breast cancer treatment paradigm?
Rafael Grochot • 2 Jul 2026
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
1:35
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
Rafael Grochot • 2 Jul 2026
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
1:07
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
Sanjoy Chatterjee • 17 May 2026
Design and aim of the HYPORT study in regional nodal breast cancer
1:23
Design and aim of the HYPORT study in regional nodal breast cancer
Sanjoy Chatterjee • 17 May 2026
The content of VJOncology is intended for healthcare professionals